Abbott
ABT
Performance
About Abbott
Abbott is a global healthcare company that designs and manufactures medical devices and diagnostic solutions across cardiovascular health, diabetes management, nutrition, diagnostics testing, and related areas. With operations based in Chicago, Illinois, Abbott develops technologies and therapies to improve patient outcomes and quality of life worldwide. The company emphasizes life-changing healthcare technologies and a broad portfolio spanning medical devices, diagnostics, and medicines. Abbott serves patients and health systems globally, with products and solutions addressing a wide range of medical needs.
Recent News
Abbott Increases Quarterly Dividend for 54th Consecutive Year
Culturally Tailored Meals Improve HF Outcomes in Navajo Residents
Roche Secures CE Mark for Elecsys NfL Blood Test to Track MS Neuroinflammation
Whoop Secures $575 M Series G, Hits $10 B Valuation Ahead of IPO
Whoop Secures $575M at $10.1B Valuation Ahead of IPO Plans
Abbott's Wireless Heart Failure Sensor Cleared for NHS Use
Exact Sciences Stockholders Approve Acquisition by Abbott
Calcium Score Predictive of ASCVD Risk From Elevated Lp(a)
Should Moderate FMR Should Be Treated With M-TEER? Experts Duke It Out
GlucoTrack Shares Jump 34% as FDA IDE Submission Looms for Implantable Glucose Monitor
Medtronic Wins CE Mark for OmniaSecure Defibrillation Lead
Whoop Secures $575 M Series G at $10.1 B Valuation, Accelerating Corporate Wellness Push
Kevin Durant Whoop Valuation Up 81x Since His 2017 Investment
Questions Cloud Latest Danone Link to Mead Johnson
Multiple CGM Sensors May Be Used with Automated Insulin Delivery
VDyne Secures FDA Nod to Start Pivotal Trial for Tricuspid Valve
Remote Job Openings Jumped 20% in Q1 2026
Pulse Biosciences Hires Liane Teplitsky as COO
Neogen Corp (NEOG) Q3 2026 Earnings Call Transcript
Q&A: Obesity Medicine 2026 Will Emphasize ‘Treating the Whole Picture’
Stryker Enters Competitive IVL Space with Acquisition of Amplitude Vascular Systems
